Press release
July 17, 2014

Evonik builds dispersant plant in Essen

  • Investment in the low double digit million euro range
  • Tripling capacity for polymer dispersants
  • Rising worldwide demand for innovative dispersants for paints and printing inks

Evonik Industries is building a new production plant for polymer dispersants at the Goldschmidtstrasse site in Essen. The specialty chemicals company is thus investing an amount in the double-digit-million-euro range and is tripling its global capacity for polymer dispersants. Plans call for startup in the first quarter of 2015. Polymer dispersants are mainly used in water-based systems in paints and printing inks and in high-solid systems with a low proportion of solvent.

Dr. Ulrich Küsthardt, head of the Coatings & Additives Business Unit of Evonik: "The product group of polymer dispersants is developing in an extremely attractive way. With our expanded capacity, we want to serve this growing market. For our customers, we are a competent innovation partner; offering outstanding solutions for functional coatings and paints."

Dispersants support the trend toward more environmentally friendly and efficient paint systems. They increase color intensity and colorant yield.

Evonik markets the dispersants as additives under the name TEGO® Dispers. Because of their viscosity-lowering effect, the products permit economical production of paints and pigment concentrates by maximizing the pigment concentration during dispersion.

Evonik is a leading international manufacturer of additives for the paint and printing ink industry. With comprehensive paint competency and a global sales network, it offers its customers custom-tailored solutions worldwide. The broad product range under the umbrella brand TEGO® stands for additives, hydrophobing agents, co-binders, nanoresins, and silicone resins for demanding coating formulas.

Company information

Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.7 billion and an operating profit (adjusted EBITDA) of about €2.0 billion.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.